Dah Sing Financial Holdings Limited Overview
Dah Sing Financial Holdings is the controlling holding company of one of Hong Kong's few remaining family-controlled, locally headquartered banking groups. Through its ~74%-owned listed subsidiary Dah Sing Banking Group, it owns Dah Sing Bank in Hong Kong, Banco Comercial de Macau and Dah Sing Bank (China), operating 63 locations across the Greater Bay Area, and holds a strategic stake of roughly 13% in Bank of Chongqing. Directly, DSFH owns general insurers Dah Sing Insurance and Macau Insurance Company, a Macau pension manager, and a proprietary investment arm. The group is a mid-sized, retail-and-SME-oriented lender with total assets of HK$270bn, a deposit franchise of HK$205bn, and very strong capital (DSBG total CAR 23.4% at June 2026). Its earnings are rising on margin discipline and bancassurance-driven wealth fees, but are held back by Hong Kong commercial real estate credit costs, a loss-making Macau operation and a double-holding-company valuation discount.
The company's own description
In its 2025 results materials and group profile, DSFH describes itself as the holding company of the group's insurance and investment operations and as the majority shareholder of DSBG, which has three banking subsidiaries — Dah Sing Bank, Limited (DSB), Banco Comercial de Macau, S.A. (BCM) and Dah Sing Bank (China) Limited — plus a securities trading company (Dah Sing Securities Limited). DSB holds a strategic interest in Bank of Chongqing (BOCQ), described as the leading city commercial bank in Chongqing. The insurance business comprises general insurance through Dah Sing Insurance Company Limited (DSI) in Hong Kong and Macau Insurance Company Limited (MIC) in Macau, and pension fund management through Macau Pension Fund Management Company Limited (2025 Final Results Announcement, KPI section; 2026 Interim Press Release boilerplate).
The segment note in the 2025 Final Results Announcement states that more than 90% of revenue from external customers comes from the banking subsidiaries in Hong Kong, Macau and the PRC, with principal products being deposit taking, extension of credit, asset-based finance and securities investment services.
Business model and revenue mix
| Revenue component (DSFH, HKD Mn) | FY2024 | FY2025 |
|---|---|---|
| Net interest income | 5,401 | 5,901 |
| Net fee and commission income | 1,311 | 1,689 |
| Insurance service result after net insurance finance expense | 100 | 104 |
| Net trading income | 270 | 427 |
| Other operating income | 129 | 146 |
| Total operating income | 7,211 | 8,267 |
| Net interest income share of total operating income (%) — derived | 74.9 | 71.4 |
DSFH is a balance-sheet-driven financial group. Its revenue model is overwhelmingly spread-based, supplemented by fee income (primarily distribution of third-party life insurance and investment products), FX/trading income, general insurance underwriting, and investment returns on a proprietary equity/bond portfolio. A material share of profit comes from equity-accounted earnings of BOCQ, which do not appear in operating income.
Source: DSFH 2025 Final Results Announcement (consolidated income statement and notes 4–8).
Characterised in product/service/subscription/licensing terms: approximately 71% "spread" (lending/deposits/treasury), ~20% fee-based services (of which insurance distribution and wealth management fees are the largest), ~5% trading, ~1–2% insurance underwriting, and the balance rental/dividend income. There is no subscription or licensing revenue. The Sun Life bancassurance arrangement includes an up-front payment (HK$1.5bn) amortised over time plus ongoing variable payments, which functions similarly to a long-term distribution licence.
Fee income detail
| Fee and commission income line (DSFH, HKD Mn) | FY2024 | FY2025 |
|---|---|---|
| Insurance distribution and others | 607 | 696 |
| Retail investment and wealth management services | 209 | 443 |
| Credit card | 249 | 210 |
| Securities brokerage | 118 | 183 |
| Credit related fees and commissions | 162 | 183 |
| Other fees | 93 | 77 |
| Bank services and handling fees | 66 | 65 |
| Trade finance | 53 | 67 |
| Gross fee and commission income | 1,557 | 1,923 |
| Fee and commission expense | 246 | 234 |
Source: DSFH 2025 Final Results Announcement, note 5: ### Value-chain position, customers and end-markets
DSFH sits at the origination and balance-sheet-holding stage of the financial value chain: it gathers retail and commercial deposits, lends to households (mortgages, personal loans, cards, auto finance), SMEs and mid-corporates (property investment/development, trade, financial concerns), runs a treasury book of high-grade securities, and distributes third-party life insurance (Sun Life) and investment products. In general insurance it acts as a primary underwriter, sourcing business mainly through corporate intermediaries followed by bancassurance from DSB (AM Best, 16 Oct 2025).
Customer types: mass retail and affluent individuals (Sun Life cited 570,000 DSB retail customers in Jan 2023), high-net-worth clients (VIP Banking/private banking), SMEs and commercial/industrial companies, property investors and developers, financial institutions (as counterparties and bond issuers), and insurance policyholders (motor, employees' compensation, property, contractors' all-risks, mortgage guarantee, extended warranty).
End-markets: Hong Kong (dominant), Macau, and Mainland China (Shenzhen-centred Greater Bay Area operations plus the indirect BOCQ exposure to Western China).
Independent characterisation
Dah Sing is best characterised as a conservatively capitalised, mid-cap Hong Kong retail/SME bank wrapped in a family-controlled double holding structure. Its strategic distinctiveness rests on (a) its status as one of the last independent locally owned HK banks, (b) a sticky retail CASA base that has supported a sector-leading NIM expansion through the 2024–2025 rate-cut cycle (DSB NIM 2.17% in 2024 → 2.41% in 2025 → 2.44% in 1H2026), (c) a wealth-management engine re-ignited by the 2023 Sun Life bancassurance deal, and (d) a call option on Western China through BOCQ. Its structural weaknesses are concentration in Hong Kong property-linked lending (property development and investment loans were 19.3% of gross loans at end-2025), sub-scale and loss-making Macau operations, and returns on equity that remain below the cost of equity at the DSFH level (derived ROE ~5.7% in FY2025).
Strategy
Stated strategy themes (latest annual results and interim, paraphrased)
Resilience through the cycle: the 2024 Annual Report theme was "Building Resilience for Growth", stressing operational and financial strength across business and economic cycles.
Controllables first: for 2026 management said it would focus on disciplined cost management, selective investment in growth areas and maintaining a strong balance sheet, while remaining "cautiously optimistic" (2025 Final Results, Future Prospects).
Margin defence via deposit mix: grow CASA and control funding costs to sustain NIM through falling rates (FY2025 and 1H2026 commentary).
Wealth management as growth engine: leverage the Sun Life partnership, VIP Banking and brokerage to grow fee income (fee income +29% in both FY2025 and 1H2026).
Prudent credit management: actively reduce Hong Kong CRE exposure (HK$25.8bn end-2024 → HK$23.5bn end-2025 → HK$23.7bn Jun 2026) and manage impaired loans.
Stable dividend payout: maintain a ~40% payout supported by underlying profitability.
Greater Bay Area connectivity: cross-border services via DSB (China)'s dual-licensed Shenzhen Branch.
Strategic initiatives in the last 24 months
| Initiative | Date | Detail | Status |
|---|---|---|---|
| Sun Life bancassurance scale-up | 2023–2026 | First two years completed; wealth business achieved stronger results for the second consecutive year | Ongoing |
| VIP Banking campaign "Intelligent Wealth Solutions" | 2 Feb 2026 | Wealth/legacy planning, principal-protected products, bonds, structured products, AI-supported market intelligence | Launched |
| 24-hour US stock trading | Early 2026 | Extended-hours US equity trading for retail clients | Launched |
| Wong Chuk Hang premises | 27 Feb 2026 | HK$838.7m acquisition with naming rights; consolidates operations and reduces future lease dependence | Agreed |
| Auditor rotation | 2,026 | PwC to KPMG from FY2026 (DSBG) following tender | Proposed/approved at AGM |
| HKD rate repricing | 22 Sep 2025 | Prime rate cut to 5.375%; HKD deposit rate cut to 0.125% | Implemented |
| Insurance growth | 2025–2026 | Extended warranty and property damage lines driving 11% GPW growth in 1H2026 | Ongoing |
| Cost programmes with targets | — | No quantified cost programme disclosed | — |
| ESG commitments | — | No quantified group targets found | — |
Medium-term financial targets
DSFH does not publish quantified medium-term targets for ROE, cost-to-income, loan growth or capital in the materials reviewed — not publicly disclosed. Implicit guidance: dividend payout ratio "stable" at ~40%; capital and liquidity "sound".
Products & Services
Pricing for banking products is market-rate based and not disclosed in aggregate. Launch years are given only where verified.
Personal Banking (DSB, Hong Kong)
| Product / service | Description and capabilities | Target customer | Latest verified data point |
|---|---|---|---|
| Residential mortgages | Loans for private residential property and subsidised housing (HOS/PSPS/TPS) | Homebuyers | HK$32.6bn private residential + HK$0.29bn subsidised flats at end-2025 (23.4% of loans) |
| Personal loans and overdrafts | Unsecured consumer credit | Mass retail | Included in "Individuals – Others" HK$18.2bn at end-2025 (up from HK$14.0bn) |
| Credit cards | Card issuing and merchant-related fees | Mass retail | Card advances HK$3.68bn; card fee income HK$210m (FY2025) |
| Vehicle financing | Auto and asset-based consumer finance | Retail, owner-drivers | Balance not separately disclosed |
| Deposits / CASA | Savings, current and time deposits; HKD deposit rate reference 0.125% p.a. from 22 Sep 2025 | All retail | Group customer deposits HK$204.7bn at end-2025 |
| Bancassurance (Sun Life) | Exclusive distribution of Sun Life Hong Kong life and health insurance through DSB, 15-year term, live since Jul 2023 | Retail, affluent | Insurance distribution fees HK$696m (FY2025) |
| Wealth management / retail investment | Funds, bonds, structured products, principal-protected solutions, advisory | Affluent, HNW | Retail investment & WM fees HK$443m (FY2025, +111%) |
| VIP Banking | Wealth and legacy planning; campaign "Intelligent Wealth Solutions · Unlocking New Opportunities" launched 2 Feb 2026, with AI-supported market intelligence | Affluent and HNW | Launched Feb 2026 (Caproasia) |
| Private banking | Referenced in DSB service scope | HNW | Data not publicly disclosed |
| Securities brokerage (Dah Sing Securities) | HK and US equities; 24-hour US stock trading launched early 2026 | Retail investors | Brokerage fees HK$183m (FY2025, +54%) |
| Digital banking | Mobile and online banking; company states significant ongoing investment | Retail | Specific platform metrics not publicly disclosed |
Corporate Banking
| Product / service | Description | Target customer | Latest data |
|---|---|---|---|
| Property investment lending | Term loans secured on HK commercial/residential investment property | Property investors | HK$21.3bn (15.2% of loans) end-2025 |
| Property development lending | Construction/development finance | Developers | HK$5.7bn (4.1%) end-2025 |
| Commercial and industrial lending | Working capital, term loans to manufacturing, trade, transport, IT | SMEs, mid-corporates | Wholesale/retail HK$3.6bn; transport HK$2.3bn; manufacturing HK$1.4bn |
| Lending to financial concerns and stockbrokers | Credit lines to non-bank financials | Financial institutions | HK$6.6bn and HK$0.7bn |
| Trade finance | Import/export/re-export finance, trade bills | Trading SMEs | Trade finance loans HK$4.7bn; trade bills HK$2.35bn; trade fees HK$67m |
| Cash management and treasury solutions | Payments, FX, hedging for corporates | Commercial clients | — |
| Cross-border (GBA) services | Business matching and cross-border finance, including under Norinchukin alliance | GBA and Japanese-linked clients | Qualitative only |
Treasury and Global Markets
| Product / activity | Description | Latest data |
|---|---|---|
| FX dealing and customer sales | Spot/forward FX for retail and corporate clients | FX dealing gains HK$313m (FY2025) |
| Investment securities portfolio | FVOCI debt HK$43.3bn; amortised cost HK$34.0bn; trading HK$2.1bn | End-2025 |
| Funding and liquidity management | Central funding, CD issuance (HK$0.9bn), swap funding | Average LMR above 60% in 2025 |
| Interest rate risk management | ALM hedging, fair value hedges | — |
Chinese Mainland and Macau
| Entity / product | Description | Latest data |
|---|---|---|
| Banco Comercial de Macau | Full-service retail and commercial bank in Macau | Macau total operating income HK$507m; PBT -HK$362m (FY2025, incl. goodwill write-off) |
| Dah Sing Bank (China) | Mainland commercial bank; Shenzhen Branch holds a "Dual Operating Licence" (2023) enabling both onshore and cross-border business | Net profit rose in 1H2026 |
| Bank of Chongqing (associate) | ~13% stake; equity-accounted | Share of profit HK$729m (FY2025); HK$511m (1H2026); carrying value HK$2.97bn |
Insurance and Investment Operations
| Line of business (GPW, HKD Mn) | FY2024 | FY2025 |
|---|---|---|
| Motor vehicle | 365 | 409 |
| Employees' compensation | 291 | 296 |
| Property damage | 296 | 294 |
| Contractors' all risks | 107 | 108 |
| Mortgage guarantee | 0 | 14 |
| Others (incl. extended warranty) | 188 | 268 |
| Total gross premiums written | 1,246 | 1,390 |
| Entity / service | Description |
|---|---|
| Dah Sing Insurance Company Limited | Hong Kong general insurer; AM Best FSR A- (Excellent), ICR "a-", outlook positive (Oct 2025); RBC ratio 285% (end-2025) |
| Macau Insurance Company Limited | Macau general insurer; solvency ratio 1,042% (end-2025) |
| Macau Pension Fund Management Company | Pension fund management in Macau |
| Group investment operations | Wholly owned entities deploying DSFH capital; insurance plus group investment AUM HK$11.9bn (end-2025) and HK$13.1bn (Jun 2026) |
Source: 2025 Final Results Announcement KPI section. FY2024 mortgage guarantee GPW was -HK$0.165m.
Financial Narrative
Income statement: notes and sources
Notes: FY2021 total operating income is "net of insurance claims" (pre-HKFRS 17). FY2022 is the HKFRS 17-restated figure (originally reported profit attributable HK$1,171m and operating income HK$6,996m). FY2022 PBT of HK$1,970m (DSBG) and DSFH PBT pre-restatement not used. FY2023 PBT of HK$2,356m is the comparative in the FY2024 announcement. FY2022 profit for the year is the originally reported figure. BOCQ impairment amounts for FY2021–FY2023 are from the 2023 Annual Results Presentation chart (DSBG level). Gross profit and EBITDA are not meaningful for a bank.
Sources: DSFH final results announcements FY2021–FY2025; 2023 and 2025 Annual Results Presentations.
Margins and growth (derived)
FY2025 cost-to-income is the company-stated 43.3% (banking business 43.5%). FY2022 cost-to-income is flattered by the HK$1,394m bancassurance termination gain. NIM per DSBG presentations.
Revenue CAGR (FY2021–FY2025, derived): total operating income grew from HK$5,676m to HK$8,267m, a 9.9% CAGR — but the base-year basis differs (pre-HKFRS 17) and FY2022 contains a one-off gain, so the underlying organic CAGR is better measured over FY2023–FY2025: 15.1% CAGR (HK$6,243m → HK$8,267m). Basic EPS CAGR (FY2021–FY2025): 12.1%.
Balance sheet
FY2022 figures are as restated in the FY2023 announcement (originally total assets HK$259,847m; shareholders' funds HK$29,520m). FY2021 and FY2022 non-controlling interests derived as total equity less shareholders' funds. BVPS derived using ~319.0m shares (FY2021–FY2024) and 318.9m (FY2025). Net debt and working capital are not meaningful for a bank; cash-like assets (cash + 1–12-month placements) were HK$24.1bn at end-2025.
Funding and debt structure (end-2025): Customer deposits HK$204.7bn (75.7% of total assets — derived); deposits from banks HK$0.28bn; CDs issued HK$0.89bn (down sharply from HK$4.30bn as deposit growth replaced wholesale funding); subordinated notes HK$4.27bn (US$300m due 2031 and US$250m due 2033 Tier 2 at DSB level); DSB also has US$150m of Additional Tier 1 instruments in its capital base (US$110m + US$40m, per DSB capital disclosure Nov 2023). There is no short-term/long-term "corporate debt" split in the conventional sense; all wholesale debt is bank capital or money-market funding.
Cash flow
Operating cash flow from Stoxray aggregator; for banks it reflects loan/deposit movements and is not an indicator of earnings quality. FY2024–FY2025 dividends from the 2025 announcement; FY2022–FY2023 derived from DPS × shares. No buyback programme; the Share Award Scheme trustee bought 118,000 shares for HK$3.13m in FY2025. The Viva Place property purchase (~HK$839m, 2026) is the largest identified fixed-asset outlay.
Return and risk ratios
ROIC, current ratio, net debt/EBITDA, interest coverage, asset turnover and cash conversion cycle are not applicable to banks. Capital/liquidity ratios per DSBG presentations (FY2021 from 2021 presentation). Impaired loan ratios FY2022–FY2023 read from 2023 presentation chart (moderate confidence); FY2024–FY2025 from 2025 announcement note 16.
Interim periods
1H2024 DSFH operating income derived from 1H2025 +21% growth (press release); other figures per 2024–2026 interim press releases and presentations.
Commentary on trends, inflections and drivers
FY2021–FY2022: a distorted base. FY2022 headline earnings were whipsawed by two large one-offs at the DSBG level: a HK$1,394m gain from terminating the previous bancassurance distribution agreement (put in place with the life insurance sale of 2016–17) and a HK$1,385m BOCQ impairment caused by a valuation model update (total BOCQ impairment HK$1,683m). Excluding both, DSBG's 2022 profit was HK$1,695m by company calculation. DSFH profit fell to HK$1,224m (restated) despite a 23% rise in operating income.
FY2023: the fee-income air pocket. With no bancassurance fees in 1H2023 (the old agreement had ended; Sun Life distribution started only in July 2023), DSFH fee income collapsed 62% to HK$851m. Net interest income rose 12% on higher rates, BOCQ impairment fell to HK$552m and profit rose 30% to HK$1,592m.
FY2024: margin up, credit costs up. NIM widened to 2.17% and fee income recovered to HK$1,311m (bancassurance and wealth), driving a 26% rise in pre-impairment operating profit. However, credit impairment charges rose 145% to HK$1,791m (DSBG), concentrated in HK commercial real estate and some Mainland exposures, so profit rose only 5%. The impaired loan ratio jumped from ~1.9% to 3.21%.
FY2025: the inflection year. NIM expanded a further 24bp to 2.41% despite Federal Reserve rate cuts — the company credits CASA growth and funding-cost discipline — and fee income rose 29% as wealth fees more than doubled. Cost-to-income fell to 43.3%. Credit costs were flat at HK$1.78bn. Profit attributable rose 23% to HK$2,057m even after the non-cash HK$493m write-off of BCM goodwill. Excluding that write-off, attributable profit would have been roughly HK$2.42bn (derived, before minority share considerations — BCM sits under DSBG, so DSFH's attributable portion is ~74% of the charge; this estimate is approximate).
1H2026: slowing but still positive. DSBG profit rose 13% and its annualised ROE reached 10.0%, but DSFH profit rose only 4% because the insurance/trading line fell 33% (high base from 1H2025 investment gains and higher swap funding costs). Credit costs remained elevated at HK$724m, with corporate banking provisions up 26%.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Relationship | Business |
|---|---|---|
Dah Sing Financial Holdings Limited (0440) | Listed parent | Holding company; insurance and investment operations |
Dah Sing Banking Group Limited (2356) | — | Bank holding company |
Dah Sing Bank, Limited | 100% of DSBG | Licensed bank in Hong Kong |
Banco Comercial de Macau, S.A. | 100% of DSB | Bank in Macau |
Dah Sing Bank (China) Limited | 100% of DSB | Bank in Mainland China (Shenzhen-based) |
Dah Sing Securities Limited | Within DSBG | Securities trading |
Dah Sing Properties Limited | Indirect wholly owned subsidiary of DSBG | Property holding (Viva Place purchaser) |
Bank of Chongqing | ~13% associate of DSB | City commercial bank, Western China |
Dah Sing Insurance Company Limited | Owned by DSFH | General insurance, Hong Kong |
Macau Insurance Company Limited | Non-wholly-owned subsidiary of DSFH | General insurance, Macau |
Macau Pension Fund Management Company Limited | Owned by DSFH | Pension fund management, Macau |
Investment operations entities | Wholly owned by DSFH | Securities investment and cash deployment arm |
Segment Revenue
| Segment | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Personal Banking operating income | — | 3,498 | 3,930 |
Corporate Banking operating income | — | 1,298 | 1,258 |
Treasury and Global Markets operating income | — | 1,536 | 2,214 |
Chinese Mainland and Macau Banking operating income | — | 630 | 711 |
Insurance and Investment Operations operating income | — | 308 | 345 |
Others operating income | — | -8 | -131 |
Inter-segment elimination | — | -51 | -61 |
Total operating income | 6,243 | 7,211 | 8,267 |
Segment Revenue (FY2024–FY2025)
| Segment | FY2024 | FY2025 |
|---|---|---|
Personal Banking PBT | 1,050 | 1,521 |
Corporate Banking PBT | -320 | -405 |
Treasury and Global Markets PBT | 1,214 | 1,876 |
Chinese Mainland and Macau Banking PBT | 554 | 286 |
Insurance and Investment Operations PBT | 176 | 165 |
Others PBT | -127 | -369 |
Total PBT | 2,547 | 3,075 |
Segment (FY2025) Overview
| Segment (FY2025) | Op income YoY (%) | Share of total op income (%) | Pre-impairment margin (%) | Credit impairment (HKD Mn) | PBT YoY (%) |
|---|---|---|---|---|---|
Personal Banking | 12.4 | 47.5 | 50.5 | 464 | 44.8 |
Corporate Banking | -3.1 | 15.2 | 58.6 | 1,143 | loss widened |
Treasury and Global Markets | 44.1 | 26.8 | 86.7 | 42 | 54.6 |
Chinese Mainland and Macau | 12.9 | 8.6 | 17.9 | 131 | -48.4 |
Insurance and Investment Ops | 12.1 | 4.2 | 52.2 | 0 | -6.2 |
Segment Overview
| Segment | 1H2026 vs 1H2025 (per company) |
|---|---|
Personal Banking | NII +4%; non-interest income +26%; pre-impairment profit +23%; impairments -4%; profit +36% |
Corporate Banking | NII +6%; non-interest income -6%; pre-impairment profit +11%; provisions +26%; net profit -58% |
Treasury and Global Markets | Operating income +0.3%; NII +8%; non-interest income -57%; operating profit +1%; impairment write-backs |
Chinese Mainland | NII up; non-interest income up substantially; BOCQ profit share +16% |
Macau | NII and non-interest income down; net loss widened slightly |
Insurance and Investment Ops | GPW +11%; combined ratio 90%; OCI MTM/disposal gains 1.8x to HK$1.1bn; investment AUM +11% to HK$13.1bn |
Income Statement and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Net interest income (HKD Mn) | — | 4,431 | 4,951 | 5,401 | 5,901 |
Net fee and commission income (HKD Mn) | — | 2,236 | 851 | 1,311 | 1,689 |
Total operating income (HKD Mn) | 5,676 | 6,986 | 6,243 | 7,211 | 8,267 |
Operating expenses (HKD Mn) | 3,205 | 3,104 | 3,250 | 3,443 | 3,577 |
Credit impairment losses (HKD Mn) | — | 804 | 731 | 1,790 | 1,783 |
Operating profit after credit impairment (HKD Mn) | 2,099 | 3,078 | 2,262 | 1,978 | 2,906 |
Share of profit of BOCQ (HKD Mn) | 698 | 657 | 689 | 677 | 729 |
Impairment on investment in BOCQ (HKD Mn) | 726 | 1,683 | 552 | 16 | 0 |
BCM goodwill impairment (HKD Mn) | 0 | 0 | 0 | 0 | 493 |
Profit before tax (HKD Mn) | — | — | 2,356 | 2,547 | 3,075 |
Profit for the year incl. minorities (HKD Mn) | 1,735 | 1,584 | 2069 | 2,201 | 2,691 |
Profit attributable to shareholders (HKD Mn) | 1,308 | 1,224 | 1,592 | 1,673 | 2,057 |
Basic EPS (HKD) | 4.09 | 3.83 | 4.99 | 5.25 | 6.45 |
Diluted EPS (HKD) | — | — | 4.11 | 4.36 | 5.47 |
Dividend per share (HKD) | — | 1.14 | 2.00 | 2.10 | 2.58 |
Margin Analysis (%)
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Cost-to-income ratio (%) | 56.5 | 44.4 | 52.1 | 47.7 | 43.3 |
Credit cost as % of total op income (%) | — | 11.5 | 11.7 | 24.8 | 21.6 |
Attributable net margin on op income (%) | 23.0 | 17.5 | 25.5 | 23.2 | 24.9 |
Total op income YoY growth (%) | — | 23.1 | -10.6 | 15.5 | 14.6 |
Attributable profit YoY growth (%) | 13.0 | -6.4 | 30.1 | 5.1 | 22.9 |
DSB net interest margin (%) | — | 1.85 | 2.01 | 2.17 | 2.41 |
Dividend payout ratio on basic EPS (%) | — | 29.8 | 40.1 | 40.0 | 40.0 |
Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets (HKD Mn) | 256,531 | 259,159 | 269,789 | 266,523 | 270,380 |
Cash and balances with banks (HKD Mn) | — | — | — | 15,010 | 15,743 |
Placements with banks 1–12 months (HKD Mn) | — | — | — | 5,796 | 8,317 |
Gross loans and advances to customers (HKD Mn) | — | — | — | 138,374 | 140,158 |
Investment securities FVOCI + amortised cost (HKD Mn) | — | — | — | 86,782 | 86,994 |
Investment in associate BOCQ (HKD Mn) | — | — | — | 2,533 | 2,968 |
Goodwill and intangibles (HKD Mn) | — | — | — | 878 | 385 |
Customer deposits (HKD Mn) | — | — | — | 200,599 | 204,733 |
Certificates of deposit issued (HKD Mn) | — | — | — | 4,295 | 888 |
Subordinated notes (HKD Mn) | — | — | — | 4,147 | 4,275 |
Total liabilities (HKD Mn) | 218,705 | 221,924 | 228,790 | 223,325 | 223,894 |
Shareholders' funds (HKD Mn) | 30,192 | 29,601 | 32,682 | 34,642 | 37,490 |
Non-controlling interests (HKD Mn) | 7,634 | 7,634 | 8,317 | 8,556 | 8,996 |
Total equity (HKD Mn) | 37,826 | 37,235 | 40,999 | 43,198 | 46,486 |
Book value per share (HKD) — derived | 94.4 | 92.6 | 102.4 | 108.6 | 117.6 |
Cash Flow
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow (HKD Mn) — aggregator | 3,927 | 5,545 | -2,099 | -3,334 | — |
Dividends declared for the year (HKD Mn) | — | 364 | 637 | 669 | 823 |
Share buybacks (HKD Mn) | 0 | 0 | 0 | 0 | 0 |
Margin Analysis (%) and Balance Sheet
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
DSFH ROE on avg shareholders' funds (%) — derived | — | 4.1 | 5.1 | 5.0 | 5.7 |
DSFH ROA attributable on avg assets (%) — derived | — | 0.47 | 0.60 | 0.62 | 0.77 |
DSBG return on avg shareholders' funds (%) | — | 5.4 | 6.0 | 6.2 | 7.2 |
DSBG return on avg total assets (%) | — | 0.6 | 0.7 | 0.8 | 1.0 |
Equity to assets (%) — derived | 14.7 | 14.4 | 15.2 | 16.2 | 17.2 |
Loan to deposit ratio (%) — derived | — | — | — | 69.0 | 68.5 |
DSBG CET1 ratio (%) | 14.2 | 15.2 | 16.2 | 16.9 | 18.8 |
DSBG total capital ratio (%) | 18.1 | 19.3 | 21.2 | 21.0 | 23.1 |
DSBG liquidity maintenance ratio (%) | 46.9 | 50.4 | 64.0 | 64.2 | 60.8 |
Impaired loan ratio (%) | — | 1.86 | 1.94 | 3.21 | 3.12 |
ECL allowances (HKD Mn) | 1,378 | 1,642 | 1,116 | 1,533 | 2,230 |
Per-Share Data and Margin Analysis (%)
| Metric | 1H2024 | 1H2025 | 1H2026 |
|---|---|---|---|
DSFH total operating income | 3,398 | 4,112 | 4,318 |
DSFH operating profit after credit impairment | 1,226 | 1,602 | 1,789 |
DSFH profit attributable to shareholders | 1,112 | 1,406 | 1,458 |
DSFH basic EPS (HKD) | 3.49 | 4.41 | 4.57 |
DSFH interim DPS (HKD) | 0.92 | 1.16 | 1.20 |
DSBG profit attributable to shareholders | 1,396 | 1,579 | 1,780 |
DSBG NIM (%) | 2.09 | 2.32 | 2.44 |
DSBG credit impairment losses | 544 | 728 | 724 |
BOCQ share of profit | 430 | 443 | 511 |
Geographic Revenue
| Region | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Hong Kong and others total operating income | — | 6,757 | 7,762 |
Macau total operating income | — | 456 | 507 |
Inter-segment elimination | — | -2 | -2 |
Group total operating income | 6,243 | 7,211 | 8,267 |
Hong Kong and others PBT | — | 2,470 | 3,437 |
Macau PBT | — | 77 | -362 |
Hong Kong and others total assets | — | 244,669 | 251,128 |
Macau total assets | — | 26,966 | 24,483 |
Region Overview
| Region | Operating income growth (%) | Share of group operating income FY2025 (%) | Asset growth (%) |
|---|---|---|---|
Hong Kong and others | 14.9 | 93.9 | 2.6 |
Macau | 11.2 | 6.1 | -9.2 |
Geographic Revenue (FY2024–FY2025)
| Loan category | FY2024 | FY2025 |
|---|---|---|
Loans for use in Hong Kong | 102,052 | 102,886 |
Trade finance | 4,902 | 4,663 |
Loans for use outside Hong Kong | 31,419 | 32,610 |
Gross loans and advances | 138,374 | 140,158 |
Share Price History
| Date | Price | Source |
|---|---|---|
5 Jul 2022 | 24.25 (MUFG block trade) | Bloomberg via BNN |
12-month range to c.Oct 2025 | 24.00 – 37.24 | TipRanks |
24 Feb 2026 | 42.08 | Stoxray |
15 Mar 2026 | 39.48 | Investing.com |
15 Apr 2026 | 41.96 (52-week range 25.80 – 43.56) | Google Finance |
21 Apr 2026 | 41.62 | Investing.com |
23 Jul 2026 | 43.16 | Investing.com |
28 Jul 2026 | 49.52 | Investing.com |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
P/E (FY2025 basic EPS HK$6.45) | 7.7x | Derived |
P/E (trailing 12 months to Jun 2026, EPS HK$6.61) | 7.5x | Derived (2H25 HK$2.04 + 1H26 HK$4.57) |
P/B (end-2025 BVPS ~HK$117.6) | 0.42x | Derived |
Dividend yield (trailing: HK$1.42 + HK$1.20) | 5.3% | Derived |
Market cap / total operating income (FY2025) | 1.9x | Derived (EV/Sales proxy) |
EV/EBITDA | n/a (bank) | — |
Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
DSFH DPS (HKD) | — | 1.14 | 2.00 | 2.10 | 2.58 |
DSFH interim DPS (HKD) | — | 0.33 | 0.36 | 0.92 | 1.16 |
DSFH final DPS (HKD) | 0.73 | 0.81 | 1.64 | 1.18 | 1.42 |
DSBG DPS (HKD) | — | 0.39 | 0.60 | 0.66 | 0.80 |
Group Entities — Dah Sing Bank
| Entity | Agency | Rating | Outlook | Source / date |
|---|---|---|---|---|
Dah Sing Bank | Moody's | A2 (long-term) | — | Group Profile web page (current) |
Dah Sing Bank | Fitch | BBB+ (Long-Term IDR) | Stable (per undated Fitch peer review) | Group Profile; Fitch commentary |
Dah Sing Insurance | AM Best | FSR A- (Excellent); ICR "a-" | Positive (revised 16 Oct 2025) | AM Best |
Macau Insurance | AM Best | A- (2023 reaffirmation) | — | 2023 Annual Results Presentation |
DSFH | — | Not rated (holding company) | — | — |
Capital Instruments
| Instrument | Amount | Maturity | Notes |
|---|---|---|---|
Tier 2 Dated Subordinated Notes (ISIN XS2393542548) | US$300m | 2031 | — |
Tier 2 Dated Subordinated Notes | US$250m | 2033 | — |
Additional Tier 1 Capital Securities | US$110m + US$40m | Perpetual | Per DSB capital disclosure, Nov 2023 |
Certificates of deposit issued | HK$0.89bn | Short-term | End-2025 |
Redeemed | US$250m Tier 2 due 2026 (Dec 2021); US$225m Tier 2 due 2029 (Jan 2024); US$225m Tier 2 due 2024 | — | — |
Analyst Conclusions
Management guidance
Management is "cautiously optimistic" for 2026, expecting steady Hong Kong growth, a continued residential recovery, somewhat improving CRE demand, and continued focus on cost discipline, selective growth investment and balance-sheet strength. In August 2026 the CEO expressed confidence that the group's financial foundation supports long-term sustainable growth. No quantified targets are given.
Consensus expectations
Broad consensus estimates are not available (single-analyst coverage). Annualising 1H2026 implies FY2026 DSFH EPS of roughly HK$6.6–7.0 (analyst estimate, assuming a seasonally weaker second half as in 2025, and no goodwill write-off), versus HK$6.45 in FY2025.
Bull case
-
Structural NIM uplift persists: CASA-led margin of 2.44% plus stable credit costs could lift DSBG ROE sustainably toward 10%, translating to DSFH ROE of ~7–8% and justifying a re-rating from 0.42x book.
-
Wealth/bancassurance compounding: fee income has grown ~29% two periods running; the Sun Life contract's variable payments scale with sales, giving operating leverage at a 43% cost-to-income ratio.
-
Capital release: with CET1 at 19.1%, the group could raise payouts or buy back stock; even holding a 40% payout, DPS has risen 126% from FY2022 to FY2025.
Bear case
-
CRE credit tail: corporate banking remains loss-making; Stage 2 allowances tripled in FY2025 and corporate provisions rose 26% in 1H2026 — further downgrades could push credit costs above HK$2bn.
-
Margin peak: prime and deposit rates are already low (savings 0.125%); with limited room to cut funding costs further, additional rate cuts would compress asset yields, while swap funding costs weigh on trading income.
-
Structural discount endures: family control (~40%), double holdco structure, Macau losses and thin liquidity may keep the stock anchored at a deep discount to book regardless of earnings.
Catalysts and monitorables (next 12 months)
| Monitorable | Why it matters |
|---|---|
| FY2026 results (expected late March 2027) | Second-half credit costs and NIM trajectory |
| Impaired loan ratio (3.03% at Jun 2026) and HKCRE impaired balance (HK$1.70bn) | Confirms whether credit has peaked |
| Potential call of US$300m 2031 Tier 2 notes and any replacement issue | Capital management signal and funding cost |
| BCM restructuring or strategic review | Macau loss elimination would add directly to earnings |
| BOCQ profit and dividend | ~25% of DSFH pre-tax profit (derived: HK$729m of HK$3,075m in FY2025) |
| Dividend payout decisions | Any move above 40% would signal capital return intent |
| Wong Chuk Hang completion and cost savings | Lease expense reduction |
| HKD interest rates and HIBOR–LIBOR/SOFR spread | Drives NIM and swap costs |
| Ownership changes (Norinchukin, Wong family) | Potential strategic/consolidation signal |
| Auditor transition to KPMG | Any changes in accounting judgements (e.g., BOCQ valuation, ECL) |
Analyst verdict
Dah Sing Financial Holdings has, in the 2024–2026 period, quietly executed one of the better operating turnarounds among Hong Kong's mid-tier banks. The evidence is in the numbers: DSB's net interest margin rose about 60 basis points from 2022 to 1H2026 even as the US easing cycle compressed sector spreads; fee income recovered from a 2023 trough of HK$851m to HK$1.69bn in FY2025 on the back of the Sun Life partnership and a revived wealth business; cost-to-income fell below 44%; and capital climbed to a CET1 ratio of 19.1%. Basic EPS reached a record HK$6.45 in FY2025 and dividends rose 23%.
Yet the investment case remains bounded by three stubborn facts. First, credit costs have reset structurally higher: impairment charges near HK$1.8bn per year consume roughly 38% of pre-impairment operating profit, and the corporate book — dominated by Hong Kong property investment lending — has been loss-making for two years. Second, the Macau franchise has moved from under-earning to value-destroying, as the full goodwill write-off acknowledged. Third, the group's governance and structure — a ~40% family stake, a listed holdco over a listed bank, and thin trading — continue to justify a meaningful valuation discount, and the holdco's ROE (~5.7%) still trails its cost of equity.
At ~0.42x book and a ~5% yield (late-July 2026 pricing), the market is pricing Dah Sing as a stable, low-return utility. That is too pessimistic if credit costs normalise even modestly: a reduction of HK$500m in annual impairments would lift DSFH earnings by roughly 15–20%. Our overall view is constructive but conditional — the risk-reward favours patient investors, with confirmation hinging on a sustained decline in the impaired loan ratio below 3% and evidence that management will deploy its surplus capital, whether through higher payouts, a BCM restructuring, or capital returns.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Notes |
|---|---|---|
David Shou-Yeh Wong | Chairman, Executive Director | Long-serving chairman; also chairs DSBG and DSI; controlling shareholder. |
Hon-Hing Wong (Derek Wong) | Vice Chairman, Managing Director and Chief Executive, Executive Director | Also Vice Chairman, MD & CE of DSBG; MD & CE since at least 2022 |
Harold Tsu-Hing Wong | Group General Manager, Executive Director | — |
Gary Pak-Ling Wang | Deputy Chief Executive, Executive Director | Also on DSBG board |
Toshiaki Hatakenaka | Non-Executive Director (alternate: Yuichi Tashita) | Japanese nominee; likely associated with The Norinchukin Bank (inference, not confirmed) |
Robert Tsai-To Sze | Independent Non-Executive Director | Also DSBG INED |
Andrew Kwan-Yuen Leung | Independent Non-Executive Director | — |
Paul Franz Winkelmann | Independent Non-Executive Director | Also DSBG INED |
Mariana Suk-Fun Ngan | Independent Non-Executive Director | Former MUFG Hong Kong Branch senior executive (Co-Head; Executive Officer of MUFG); appointed 2022 |
Wing-Yiu Chu (Alex Chu) | Independent Non-Executive Director | — |
Executive Leadership Team
| Name | Role |
|---|---|
Cliff Chan | Executive Director and Group Head of Wealth Management, Dah Sing Bank (Caproasia, Feb 2026) |
Richard Tsung-Yung Li | Company Secretary, DSFH and DSBG |
Governance Overview
| Indicator | DSFH |
|---|---|
Board size | 10 |
Executive directors | 4 (40%) |
Non-executive (non-independent) | 1 (10%) |
Independent non-executive | 5 (50%) |
Women on board | 1 (10%) |
Chair/CEO separation | Yes in title (Chairman David Wong; CE Derek Wong), but both are executive and the group is family-controlled |
Corporate Governance Code compliance | Company states it applied the principles and complied with the code provisions throughout FY2025 |
Major Shareholders
| Holder | Approx. stake (%) | Shares (approx.) | Source / date |
|---|---|---|---|
David Shou-Yeh Wong (and controlled entities) | 39.5 | 126.2m | Simply Wall St (recent); an earlier snapshot showed 43.0% |
Norinchukin Zenkyoren Asset Management / The Norinchukin Bank | 10.0 | 32.0m | Simply Wall St; acquired from MUFG Jul 2022 |
Aberdeen Group plc (abrdn) | 5.65 | 18.0m | Simply Wall St |
The Vanguard Group | 2.21 | 7.1m | Simply Wall St |
Dimensional Fund Advisors | 1.90 | 6.1m | Simply Wall St |
Harold Tsu-Hing Wong | 1.13 | 3.6m | Simply Wall St |
Hartford Funds Management | 0.95 | 3.0m | Simply Wall St |
BlackRock | 0.82 | 2.6m | Simply Wall St |
Norges Bank Investment Management | 0.73 | 2.3m | Simply Wall St |
American Century Investment Management | 0.49 | 1.6m | Simply Wall St |
Competitive Landscape
Competitors by Segment
| Segment | Competitors | Relative positioning |
|---|---|---|
Hong Kong retail banking | HSBC, Hang Seng Bank (subject to HSBC privatisation proposal announced Oct 2025 — status should be verified), Bank of China (Hong Kong), Standard Chartered HK, Bank of East Asia (0023), OCBC Bank (Hong Kong) (formerly Wing Hang), Public Bank (Hong Kong), Fubon Bank (HK), CMB Wing Lung | Dah Sing is a mid-tier player with ~40 branches; strengths in mortgages, cards and personal loans |
Hong Kong SME/commercial | BEA, Chong Hing Bank (Yuexiu), Shanghai Commercial Bank, China CITIC Bank International, Nanyang Commercial Bank, OCBC HK | Dah Sing competes on relationship lending and property-secured credit |
Digital/virtual banks | ZA Bank, Mox Bank, others | Pressure on deposit pricing and young retail customers |
Wealth/bancassurance | HSBC, Standard Chartered, BEA (with AIA), Citi | Sun Life tie-up gives Dah Sing a competitive shelf |
Macau banking | Bank of China Macau, Banco Nacional Ultramarino, ICBC (Macau), Tai Fung Bank, Luso International Bank, OCBC Bank (Macau) | BCM is a smaller, loss-making player |
HK/Macau general insurance | AXA General, Zurich, Chubb, China Taiping, Bank of China Group Insurance, Allied World and others | DSI combined ratio 90–93% and A- rating competitive for a mid-size insurer |
Competitor Detail
| Metric (FY2025 unless stated) | Dah Sing Financial |
|---|---|
Total operating income (HKD Bn) | 8.27 |
Op income growth (%) | 14.6 |
Cost-to-income (%) | 43.3 |
Impaired loan ratio (%) | 3.12 |
Fitch long-term rating | BBB+ (DSB) |
R&D intensity | n/a (bank) |
Recent Developments
Leadership changes, litigation, layoffs or guidance revisions in the window: none identified.*



